Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil

Bulletin of the World Health Organization

Volumn 74, Issue 5, 1996, Pages 491-500

  Linhares, A C ^a   Gabbay, Y B ^a   Mascarenhas, J D P ^a   De Freitas, R B ^a   Oliveira, C S ^a   Bellesi, N ^a   Monteiro, T A F ^a   Lins Lainson, Z ^a   Ramos, F L P ^a   Valente, S A ^a  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROTAVIRUS VACCINE;

ARTICLE; BRAZIL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT, NEWBORN; MACACA MULATTA; PROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS; SEROTYPING; VIRAL VACCINES;

EID: 8044249406     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)